Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

376 trials

Showing 20 of 376 results

Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Large-scale testing (Phase 3)Study completedNCT00053599
What this trial is testing

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 400
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Not applicableUnknownNCT03773016
What this trial is testing

Touchscreen Technology and Art for People With Dementia in Care Homes

Who this might be right for
Mild DementiaModerate Dementia
University of Nottingham 12
Testing effectiveness (Phase 2)Study completedNCT01549834
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 434
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Testing effectiveness (Phase 2)Study completedNCT02907567
What this trial is testing

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cognition Therapeutics 19
Not applicableUnknownNCT03352739
What this trial is testing

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 30
Testing effectiveness (Phase 2)Study completedNCT01343966
What this trial is testing

Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 448
Testing effectiveness (Phase 2)Study completedNCT04052737
What this trial is testing

PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Pharmazz, Inc. 80
Early research (Phase 1)Study completedNCT00397891
What this trial is testing

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 80
Testing effectiveness (Phase 2)UnknownNCT05194163
What this trial is testing

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Neurokine Therapeutics 24
Testing effectiveness (Phase 2)Ended earlyNCT00334568
What this trial is testing

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 12
Large-scale testing (Phase 3)Ended earlyNCT00490568
What this trial is testing

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,461
Testing effectiveness (Phase 2)UnknownNCT05578443
What this trial is testing

Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fujian Medical University Union Hospital 66
Large-scale testing (Phase 3)UnknownNCT03090516
What this trial is testing

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's
The First Affiliated Hospital with Nanjing Medical University 240
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Early research (Phase 1)Study completedNCT01397539
What this trial is testing

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 53
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation